Epithelial cells in bone marrow of oesophageal cancer patients: A significant prognostic factor in multivariate analysis

British Journal of Cancer

Volumn 83, Issue 1, 2000, Pages 35-39

  Thorban, S ^a   Rosenberg, R ^a   Busch, R ^a   Roder, R J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Epithelial cells in bone marrow; Multivariate analysis; Oesophageal cancer; Prognosis

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0034079460     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1199     Document Type: Article

References (28)

1. Ajani JA (1996) Therapy of carcinoma of the oesophagus: either attempt it not or succeed. Eur J Cancer 31A: 790-793
2. Anderson LL and Lad TE (1982) Autopsy findings in squamous cell carcinoma of the oesophagus. Cancer 50: 1587-1590
3. Bolton JS, Ochsner JL and Abdoh AA (1994) Surgical management of oesophageal cancer. A decade of change. Ann Surg 219: 475-480
4. Brookmeyer R and Crowley J (1982) A confidence interval for the median survival time. Biometrics 38: 29-41
5. Diel IJ and Kaufmann M (1996) Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 88: 1652-1656
6. Dittler HJ and Siewert JR (1993) Role of endoskopic ultrasonography in oesophageal cancer. Endoscopy 15: 156-161
7. Fink U, Stein HJ, Wilke HJ and Siewert JR (1995) Multimodal treatment for squamous cell oesophageal cancer. World J Surg 19: 198-204
8. Funke I and Schraut W (1998) Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 16: 557-566
9. Glickman JN, Torres C, Wang HH, Turner JR, Shahsafael A, Richards WG, Sugarbaker DJ and Odze RD (1999) The prognostic significance of lymph node micrometastasis in patients with oesophageal carcinoma. Cancer 15: 769-778
10. Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW and Schlldberg FW (1995) Individual development and uPa-receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer. Nat Med 1: 1035-1039
11. Herskovic A, Martz K and Al-Sarraf M (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. N Engl J Med 326: 1593-1598
12. Izbicki JR, Hosch SB, Pichimeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE and Pantel K (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected oesophageal cancer. N Engl J Med 337: 1188-1194
13. Johnson PWM, Burchill SA and Selby PJ (1995) The molecular detection of circulating tumour cells. Br J Cancer 72: 268-273
14. Kaplan EL and Meyer P (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53: 457-481
15. Law SYK, Fok M and Wong J (1996) Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83: 107-111
16. Lindemann F, Schlimok G, Dirschedl P, Witte J and Riethmüller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689
17. Mandard AM, Chasle J, Marnay J, Villedleu B, Blanco C and Roussel A (1981) Autopsy findings in 111 cases of oesophageal cancer. Cancer 48: 329-335
18. Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD and Seeger RC (1991) Prognostic value of imunocytological detection of bone marrow metastases in neuroblastoma. N Engl J Med 324: 219-226
19. Natsugoe S, Mueller J, Stein HJ, Feith M, Höfler H and Siewert JR (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes from oesophageal squamous eel carcinoma. Cancer 83: 858-866
20. Pantel K, Schllmok G, Braun S, Kutter D, Schaller G, Funke I, Izbicki JR and Riethmüller G (1993) Differential expression of proliferation-associated molecules in individual metastatic carcinoma cells. J Natl Cancer Inst 85: 1419-1425
21. O'Sullivan GC, Sheehan D, Clarke A, Stuart R, Kelly J, Kiely MD, Walsh T, Collins JK and Shanahan F (1999) Micrometastases in oesophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 116: 543-548
22. Riethmüller G and Johnson JP (1992) Monoclonal antibodies in the detection and therapy of micrometastatic cancers. Curr Opin Immunol 3: 647-655
23. Siewert JR and Roder JD (1992) Lymphadenectomy in oesophageal cancer surgery. Diseases of the Oesophagus 5: 91-97
24. Siewert JR, Stein HJ and Fink U (1996) Multimodality therapy for oesophageal cancer. The Oncologist 1: 210-218
25. Thorban S, Roder JD, Pantel K and Siewert JR (1996) Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma. Am J Surg 172: 297-298
26. Waish TN, Noonan N, Hollywood D, Kelly A, Keeling N and Henessy TPJ (1996) A comparison of multimodal treatment and surgery for oesophageal adenocarcinoma. N Engl J Med 335: 462-467
27. Wittekind CH and Wagner G (1997) UICC: TNM-Klassifikation maligner Tumoren. 5. Auflage, Springer-Verlag: Berlin, Heidelberg: New York
28. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA and Duhayionsod FG (1993) Survival of patients with carcinoma of the oesophagus treated with combined modality therapy. J Thorac Cardvasc Surg 105: 749-755